{"id":"https://openalex.org/W7224417835","doi":"https://doi.org/10.1007/s11899-026-00791-4","title":"The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies","display_name":"The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224417835","doi":"https://doi.org/10.1007/s11899-026-00791-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/42955162","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13719850"},"language":"en","primary_location":{"id":"doi:10.1007/s11899-026-00791-4","doi":"https://doi.org/10.1007/s11899-026-00791-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11899-026-00791-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11899-026-00791-4.pdf","source":{"id":"https://openalex.org/S35022943","display_name":"Current Hematologic Malignancy Reports","issn_l":"1558-8211","issn":["1558-8211","1558-822X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Hematologic Malignancy Reports","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11899-026-00791-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028621923","display_name":"Piyatida Chumnumsiriwath","orcid":"https://orcid.org/0000-0002-2183-0703","observed_orcids":["https://orcid.org/0000-0002-2183-0703"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210165065","display_name":"Naresuan University Hospital","ror":"https://ror.org/05qdq6h40","country_code":"TH","type":"healthcare","lineage":["https://openalex.org/I4210165065"]},{"id":"https://openalex.org/I66200439","display_name":"Naresuan University","ror":"https://ror.org/03e2qe334","country_code":"TH","type":"education","lineage":["https://openalex.org/I66200439"]}],"countries":["TH","US"],"is_corresponding":true,"raw_author_name":"Piyatida Chumnumsiriwath","raw_affiliation_strings":["Division of Hematology, Department of Medicine, Faculty of Medicine Naresuan Hospital, Naresuan University, Phitsanulok, Thailand. pkongtim@uci.edu","Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, 92868, USA. pkongtim@uci.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Medicine, Faculty of Medicine Naresuan Hospital, Naresuan University, Phitsanulok, Thailand. pkongtim@uci.edu","institution_ids":["https://openalex.org/I4210165065","https://openalex.org/I66200439"]},{"raw_affiliation_string":"Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, 92868, USA. pkongtim@uci.edu","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091083304","display_name":"Stefan Octavian Ciurea","orcid":"https://orcid.org/0000-0001-8597-3271","observed_orcids":["https://orcid.org/0000-0001-8597-3271"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan O. Ciurea","raw_affiliation_strings":["Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, 92868, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, 92868, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075342012","display_name":"Piyanuch Kongtim","orcid":"https://orcid.org/0000-0003-2130-7645","observed_orcids":["https://orcid.org/0000-0003-2130-7645"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Piyanuch Kongtim","raw_affiliation_strings":["Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, 92868, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, 92868, USA","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028621923"],"corresponding_institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210165065","https://openalex.org/I66200439"],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":{"value":3790,"currency":"USD","value_usd":3790},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.65998887,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":1.0},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.878000020980835},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.8050000071525574},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9520000219345093},{"id":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia","display_name":"childhood acute lymphoblastic leukemia","score":0.828000009059906},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9300000071525574},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5659999847412109},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.7620000243186951},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7653999924659729},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.6632999777793884},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6205000281333923},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.5684000253677368},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5231999754905701},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49619999527931213},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4957999885082245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4943000078201294},{"id":"https://openalex.org/C2993713153","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Hematopoietic cell","level":4,"score":0.4480000138282776},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.4397999942302704},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.43810001015663147},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4359000027179718},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.42730000615119934},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.42570000886917114},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4081999957561493},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.4009000062942505},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.36039999127388},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.34150001406669617},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.3287000060081482},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.32030001282691956},{"id":"https://openalex.org/C3020404979","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk stratification","level":2,"score":0.3111000061035156},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.289900004863739},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28279998898506165},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.27869999408721924},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2770000100135803},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.2728999853134155},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2718000113964081},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.2551000118255615},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2526000142097473},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.25029999017715454}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s11899-026-00791-4","doi":"https://doi.org/10.1007/s11899-026-00791-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11899-026-00791-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11899-026-00791-4.pdf","source":{"id":"https://openalex.org/S35022943","display_name":"Current Hematologic Malignancy Reports","issn_l":"1558-8211","issn":["1558-8211","1558-822X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Hematologic Malignancy Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13719850","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13719850/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13719850/pdf/11899_2026_Article_791.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Hematol Malig Rep","raw_type":"Text"},{"id":"pmid:42955162","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42955162","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current hematologic malignancy reports","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11899-026-00791-4","doi":"https://doi.org/10.1007/s11899-026-00791-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11899-026-00791-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11899-026-00791-4.pdf","source":{"id":"https://openalex.org/S35022943","display_name":"Current Hematologic Malignancy Reports","issn_l":"1558-8211","issn":["1558-8211","1558-822X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Hematologic Malignancy Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224417835.pdf","grobid_xml":"https://content.openalex.org/works/W7224417835.grobid-xml"},"referenced_works_count":81,"referenced_works":["https://openalex.org/W1274344746","https://openalex.org/W1479909146","https://openalex.org/W1480670630","https://openalex.org/W1508187469","https://openalex.org/W1511201911","https://openalex.org/W1964078594","https://openalex.org/W1965979673","https://openalex.org/W1987350756","https://openalex.org/W1989658067","https://openalex.org/W1996320020","https://openalex.org/W1999479701","https://openalex.org/W2008734787","https://openalex.org/W2017908149","https://openalex.org/W2021130630","https://openalex.org/W2038062093","https://openalex.org/W2039334806","https://openalex.org/W2048306988","https://openalex.org/W2058256886","https://openalex.org/W2065738117","https://openalex.org/W2067831127","https://openalex.org/W2073030481","https://openalex.org/W2079350261","https://openalex.org/W2085656861","https://openalex.org/W2103628120","https://openalex.org/W2122587491","https://openalex.org/W2127036836","https://openalex.org/W2128812336","https://openalex.org/W2129729973","https://openalex.org/W2131706663","https://openalex.org/W2154189404","https://openalex.org/W2155437870","https://openalex.org/W2167765664","https://openalex.org/W2315675480","https://openalex.org/W2345347338","https://openalex.org/W2481464774","https://openalex.org/W2537884769","https://openalex.org/W2590030902","https://openalex.org/W2610625257","https://openalex.org/W2737044511","https://openalex.org/W2753831100","https://openalex.org/W2794188069","https://openalex.org/W2803820671","https://openalex.org/W2811081237","https://openalex.org/W2883172656","https://openalex.org/W2891014304","https://openalex.org/W2893162866","https://openalex.org/W2895136172","https://openalex.org/W2972387925","https://openalex.org/W2996264176","https://openalex.org/W2996657019","https://openalex.org/W3003528460","https://openalex.org/W3005023235","https://openalex.org/W3010001025","https://openalex.org/W3016902363","https://openalex.org/W3022929575","https://openalex.org/W3030925457","https://openalex.org/W3031569017","https://openalex.org/W3091044444","https://openalex.org/W3108130559","https://openalex.org/W3115439304","https://openalex.org/W3133628729","https://openalex.org/W3137335378","https://openalex.org/W3207458111","https://openalex.org/W4205830254","https://openalex.org/W4311824877","https://openalex.org/W4319786746","https://openalex.org/W4387234831","https://openalex.org/W4387435594","https://openalex.org/W4388774352","https://openalex.org/W4391996353","https://openalex.org/W4395467292","https://openalex.org/W4405048517","https://openalex.org/W4411193090","https://openalex.org/W4414690693","https://openalex.org/W4415205062","https://openalex.org/W4417001771","https://openalex.org/W4417015796","https://openalex.org/W4417041660","https://openalex.org/W4417081670","https://openalex.org/W7119510811","https://openalex.org/W7127317091"],"related_works":["https://openalex.org/W2145046879","https://openalex.org/W2555334429","https://openalex.org/W3207016171","https://openalex.org/W768186762","https://openalex.org/W2136737667","https://openalex.org/W3016902363","https://openalex.org/W4404854007","https://openalex.org/W2049316098","https://openalex.org/W4405046050","https://openalex.org/W1978769772"],"abstract_inverted_index":{"PURPOSE:":[0],"Allogeneic":[1],"hematopoietic":[2],"stem":[3],"cell":[4],"transplantation":[5],"(allo-HSCT)":[6],"has":[7,176],"evolved":[8],"from":[9],"traditional":[10],"myeloablative":[11,187],"conditioning":[12,15,128,166,235],"toward":[13],"reduced-intensity":[14],"(RIC)":[16],"and":[17,36,41,64,103,112,122,131,136,146,158,170,218,224,236,242],"strategies":[18],"using":[19],"donor-derived":[20],"immune":[21,207],"effector":[22],"cells.":[23],"This":[24],"review":[25],"summarizes":[26],"trends":[27],"in":[28,77,153],"RIC,":[29],"proposes":[30],"a":[31],"practical":[32],"classification":[33],"of":[34,90,116,203,215,220],"regimens,":[35],"underscores":[37],"personalized":[38],"risk":[39,110],"stratification":[40],"disease-specific":[42,197],"conditioning.":[43],"RECENT":[44],"FINDINGS:":[45],"Fludarabine-based":[46],"backbones":[47],"combined":[48],"with":[49,80,156],"alkylating":[50],"agents-melphalan":[51],"(Flu-Mel),":[52],"busulfan":[53],"(Flu-Bu),":[54],"or":[55],"cyclophosphamide":[56],"(Flu-Cy)-remain":[57],"widely":[58],"adopted":[59],"due":[60],"to":[61,179,186,227,233,239],"favorable":[62],"tolerability":[63],"antitumor":[65],"activity.":[66],"Large":[67],"CIBMTR":[68],"analyses":[69],"indicate":[70],"melphalan-based":[71],"RIC":[72,151,175,200],"confers":[73],"superior":[74],"long-term":[75],"survival":[76,241],"older":[78],"patients":[79,155],"myeloid":[81],"malignancies,":[82],"primarily":[83],"through":[84],"reduced":[85],"relapse":[86,134,190],"rates.":[87],"The":[88],"emergence":[89],"integrated":[91],"prognostic":[92],"tools":[93],"such":[94],"as":[95],"the":[96,104],"Hematopoietic":[97],"Cell":[98],"Transplant-Composite":[99],"Risk":[100],"(HCT-CR)":[101],"score":[102],"HCT":[105],"Frailty":[106],"Scale":[107],"enhances":[108],"pretransplant":[109],"assessment":[111],"patient":[113],"selection.":[114],"Incorporation":[115],"measurable":[117],"residual":[118],"disease":[119],"(MRD)":[120],"testing":[121],"next-generation":[123],"sequencing":[124],"(NGS)":[125],"chimerism":[126],"refines":[127],"intensity":[129],"decisions":[130],"enables":[132],"earlier":[133],"detection":[135],"intervention.":[137],"While":[138],"most":[139],"prospective":[140,196],"trials":[141,198],"have":[142],"focused":[143],"on":[144],"AML":[145],"MDS,":[147],"accumulating":[148],"evidence":[149],"supports":[150],"efficacy":[152],"selected":[154],"ALL":[157],"various":[159],"lymphomas.":[160],"Collectively,":[161],"data":[162],"emphasize":[163],"that":[164],"optimal":[165],"is":[167],"disease-,":[168],"risk-,":[169],"patient-specific,":[171],"requiring":[172],"tailored":[173],"approaches.":[174],"extended":[177],"allo-HSCT":[178],"older,":[180],"frailer":[181],"patients,":[182],"achieving":[183],"outcomes":[184],"comparable":[185],"regimens":[188],"despite":[189],"risk.":[191],"Future":[192],"work":[193],"should":[194],"prioritize":[195],"comparing":[199],"regimens;":[201],"integration":[202],"dynamic":[204],"biomarkers":[205],"(MRD,":[206],"profiling,":[208],"NGS":[209],"chimerism)":[210],"into":[211],"adaptive":[212],"conditioning;":[213],"development":[214],"frailty-adjusted":[216],"protocols;":[217],"evaluation":[219],"post-transplant":[221,237],"cellular":[222],"therapies":[223],"targeted":[225],"maintenance":[226],"prevent":[228],"relapse.":[229],"These":[230],"advances":[231],"aim":[232],"personalize":[234],"management":[238],"maximize":[240],"minimize":[243],"toxicity.":[244]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2026-10-30T00:00:00"}